Relationship between cognitive function and prognosis in glioblastoma

Area of Science:

• Neuro-oncology
• Clinical Trials
• Cancer Prognostics

Background:

• Performance status is a critical factor in glioblastoma (GBM) survival prediction.
• Current performance status measures in clinical trials are often too basic.
• Advances in GBM pathology contrast with the limited assessment of patient function.

Purpose of the Study:

• To investigate the prognostic value of objective cognitive measures in glioblastoma.
• To determine if cognitive function is an independent predictor of survival.
• To advocate for the routine inclusion of cognitive assessments in clinical trials.

Main Methods:

• Analysis of objective cognitive measures in patients with newly diagnosed and recurrent glioblastoma.
• Comparison of cognitive function's predictive power against established prognostic factors.
• Evaluation of cognitive function as an independent predictor, not just a proxy for performance status.

Main Results:

• Objective cognitive measures are significantly associated with patient survival in glioblastoma.
• Cognitive function independently predicts survival, even within current prognostic systems.
• Cognitive function is not merely a proxy for overall performance status.

Conclusions:

• Objective cognitive assessment should be integrated into future glioblastoma prognostic models.
• Relying solely on new tumor biomarkers may be insufficient for improving prognostication.
• Routine, diligent evaluation and analysis of cognition are essential for advancing neuro-oncology research.